Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
about
Interventions for the management of oral ulcers in Behçet's diseaseMucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future PerspectivesAnti-inflammatory and Immunomodulatory Effects of Antibiotics and Their Use in DermatologyIs Optimal Management of Recurrent Aphthous Stomatitis Possible? A Reality CheckA double-blind trial of depot corticosteroids in Behçet's syndromeThe treatment of chronic recurrent oral aphthous ulcers.Behçet's syndrome with pyoderma-gangrenosum-like lesions treated successfully with dapsone monotherapy.Behçet's syndrome: an update.New Evidence-Based Treatment Approach in Behçet's Disease.Outcome measures used in clinical trials for Behçet syndrome: a systematic review.Behçet's disease: a review.Behçet's syndrome: disease manifestations, management, and advances in treatment.Practical aspects of management of recurrent aphthous stomatitis.Standard and novel therapeutic approaches to Behçet's disease.Intestinal complications of Behçet's diseaseEvidence-based practice in Behçet's disease: identifying areas of unmet need for 2014.Behçet's disease: an algorithmic approach to its treatment.Update on the therapy of Behçet disease.Neutrophilic dermatoses: part I.Differential diagnosis and management of Behçet syndrome.Efficacy and safety of TNF-α inhibitors in refractory primary complex aphthosis: a patient series and overview of the literature.Approaches to immunosuppression in Behçet's disease.Systemic use of non-biologic agents in orofacial diseases: other immunomodulatory agents.Behçet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions.Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approaches.Behçet's disease: review with emphasis on dermatological aspects.Acetylator phenotype in Behçet's disease.[Refractory cutaneous necrotizing vasculitis. Successful sulfone therapy].Behçet's disease
P2860
Q24193450-35580439-78D3-4043-AA2B-9F7EA5A66705Q26799767-B0A19B2E-A692-4DE2-B85D-ADF09593308EQ28069143-B103C7FF-6390-4E80-85C1-BFF1ACB9C02FQ28070375-3D7FFE77-D0BB-4D60-AAB9-4A78CE473A23Q28279953-45C57BE5-2E96-4E94-B7E8-A5F0601B3219Q34430267-5812662C-DA53-4DCA-B98A-1C79B4E9382DQ34554548-719A0DAB-65FB-4091-8BD9-38640477B5BFQ35126652-8942628C-43B8-4B5E-845F-996B0941340AQ35295186-AA925225-E920-470E-9B4D-C4B67E337518Q35868282-9A21D63A-53E3-4951-8BEA-35E15D166CDEQ36050822-773B3C59-F5FF-4229-9461-4956D97E6D70Q36749763-35FF3866-FD9E-4545-8D5C-72BF7A4171CEQ36917037-23BE3B58-01EB-4BFA-AE21-8BA0C420D6C9Q36947032-9DD6424C-4676-4356-9EC1-86383F8C3686Q37146101-AA3BD6E5-A61D-4BB8-B7ED-E225059FDC08Q37539557-739FB615-53A0-4C85-9B0B-EE276A4EEEF6Q37583633-2D11358C-BAF3-4539-917B-469B35366F9DQ37712230-942C6742-4F7A-410A-ABFA-9AFBA843405EQ37857731-D39CBD5D-4108-486C-904C-5663EEB71DBDQ38046118-B5915EA1-82BE-4487-AC8D-7FE8E1AB5A4AQ38101988-A04D9195-DA7B-421D-AC67-E1A6CE4683C7Q38119551-4ED13C77-9460-4A8D-B637-8EAE87D03AA0Q38136748-F1E4D471-02CE-422D-883B-9AD956923C73Q38807791-3F9280C5-ED15-42DF-85C0-F1FA18DB9A54Q39426072-9D981FEE-EFE4-4C83-B520-8553FF147916Q41679943-7E1878D4-96C5-460F-BA5E-9280B6A113DDQ44480953-0FEDB055-67DD-4D9F-B723-D1297E5B0B9AQ45232428-AB22BDBC-2732-4222-B203-DA2DB5A7D679Q57218126-DE9DCE63-C94E-44C0-9EA0-831776FDD171
P2860
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
@ast
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
@en
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
@nl
type
label
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
@ast
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
@en
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
@nl
prefLabel
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
@ast
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
@en
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
@nl
P2093
P2860
P1476
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
@en
P2093
Ahmed R Abu-Raghif
Khalifa E Sharquie
Rafid A Najim
P2860
P304
P356
10.1111/J.1346-8138.2002.TB00263.X
P577
2002-05-01T00:00:00Z